ACE Inhibitors in Hypertension: A Guide for General Practitioners
ACE inhibitors are one of the most exciting and interesting of recent medical developments. They fit the patho-physiologica1 processes of cardiovascular disease with fascinating precision and are a constant stimulus to the acquisition of greater understanding of the mechanisms involved and of the mo...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Dordrecht
Springer Netherlands
1992
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | ACE inhibitors are one of the most exciting and interesting of recent medical developments. They fit the patho-physiologica1 processes of cardiovascular disease with fascinating precision and are a constant stimulus to the acquisition of greater understanding of the mechanisms involved and of the mode of action of the drugs themselves. There is still much to be learned, especially about the wider effects of the drugs, their precise mode and site of action and about differences between the different preparations. ACE inhibitors are of proven benefit to patients with chronic congestive heart failure and are the latest in the series of drugs used in the treatment of hypertension. Interest in the treatment of hypertension has paralleled the development of hypotensive drugs and the realisation that long-term prognosis could be significantly improved. The treatment of hypertension has progressed in stages following the development of a succession of increasingly effective drugs, each allowing a greater proportion of patients to be treated with fewer and fewer side-effects. First, the ganglion-blocking agents such as hexamethonium and guan ethidine transformed the outlook for patients with malignant hypertension but proved too unpleasant for routine use in other forms of hypertension |
| Beschreibung: | 1 Online-Ressource (V, 107 p) |
| ISBN: | 9789401139007 |
| DOI: | 10.1007/978-94-011-3900-7 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046144771 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1992 |||| o||u| ||||||eng d | ||
| 020 | |a 9789401139007 |9 978-94-011-3900-7 | ||
| 024 | 7 | |a 10.1007/978-94-011-3900-7 |2 doi | |
| 035 | |a (ZDB-2-SME)978-94-011-3900-7 | ||
| 035 | |a (OCoLC)1118999852 | ||
| 035 | |a (DE-599)BVBBV046144771 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.12 |2 23 | |
| 100 | 1 | |a Strube, Gillian |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a ACE Inhibitors in Hypertension |b A Guide for General Practitioners |c by Gillian Strube, George Strube |
| 264 | 1 | |a Dordrecht |b Springer Netherlands |c 1992 | |
| 300 | |a 1 Online-Ressource (V, 107 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a ACE inhibitors are one of the most exciting and interesting of recent medical developments. They fit the patho-physiologica1 processes of cardiovascular disease with fascinating precision and are a constant stimulus to the acquisition of greater understanding of the mechanisms involved and of the mode of action of the drugs themselves. There is still much to be learned, especially about the wider effects of the drugs, their precise mode and site of action and about differences between the different preparations. ACE inhibitors are of proven benefit to patients with chronic congestive heart failure and are the latest in the series of drugs used in the treatment of hypertension. Interest in the treatment of hypertension has paralleled the development of hypotensive drugs and the realisation that long-term prognosis could be significantly improved. The treatment of hypertension has progressed in stages following the development of a succession of increasingly effective drugs, each allowing a greater proportion of patients to be treated with fewer and fewer side-effects. First, the ganglion-blocking agents such as hexamethonium and guan ethidine transformed the outlook for patients with malignant hypertension but proved too unpleasant for routine use in other forms of hypertension | ||
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a General Practice / Family Medicine | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Family medicine | |
| 650 | 4 | |a Toxicology | |
| 700 | 1 | |a Strube, George |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792389637 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401057370 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401139014 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-011-3900-7 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524956 | ||
| 966 | e | |u https://doi.org/10.1007/978-94-011-3900-7 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180480597164032 |
|---|---|
| any_adam_object | |
| author | Strube, Gillian Strube, George |
| author_facet | Strube, Gillian Strube, George |
| author_role | aut aut |
| author_sort | Strube, Gillian |
| author_variant | g s gs g s gs |
| building | Verbundindex |
| bvnumber | BV046144771 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-94-011-3900-7 (OCoLC)1118999852 (DE-599)BVBBV046144771 |
| dewey-full | 616.12 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.12 |
| dewey-search | 616.12 |
| dewey-sort | 3616.12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-94-011-3900-7 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02939nmm a2200469zc 4500</leader><controlfield tag="001">BV046144771</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1992 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401139007</subfield><subfield code="9">978-94-011-3900-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-011-3900-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-011-3900-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118999852</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144771</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Strube, Gillian</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">ACE Inhibitors in Hypertension</subfield><subfield code="b">A Guide for General Practitioners</subfield><subfield code="c">by Gillian Strube, George Strube</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (V, 107 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">ACE inhibitors are one of the most exciting and interesting of recent medical developments. They fit the patho-physiologica1 processes of cardiovascular disease with fascinating precision and are a constant stimulus to the acquisition of greater understanding of the mechanisms involved and of the mode of action of the drugs themselves. There is still much to be learned, especially about the wider effects of the drugs, their precise mode and site of action and about differences between the different preparations. ACE inhibitors are of proven benefit to patients with chronic congestive heart failure and are the latest in the series of drugs used in the treatment of hypertension. Interest in the treatment of hypertension has paralleled the development of hypotensive drugs and the realisation that long-term prognosis could be significantly improved. The treatment of hypertension has progressed in stages following the development of a succession of increasingly effective drugs, each allowing a greater proportion of patients to be treated with fewer and fewer side-effects. First, the ganglion-blocking agents such as hexamethonium and guan ethidine transformed the outlook for patients with malignant hypertension but proved too unpleasant for routine use in other forms of hypertension</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">General Practice / Family Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Family medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Strube, George</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792389637</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401057370</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401139014</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-011-3900-7</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524956</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-011-3900-7</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046144771 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:26Z |
| institution | BVB |
| isbn | 9789401139007 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524956 |
| oclc_num | 1118999852 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (V, 107 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Springer Netherlands |
| record_format | marc |
| spelling | Strube, Gillian Verfasser aut ACE Inhibitors in Hypertension A Guide for General Practitioners by Gillian Strube, George Strube Dordrecht Springer Netherlands 1992 1 Online-Ressource (V, 107 p) txt rdacontent c rdamedia cr rdacarrier ACE inhibitors are one of the most exciting and interesting of recent medical developments. They fit the patho-physiologica1 processes of cardiovascular disease with fascinating precision and are a constant stimulus to the acquisition of greater understanding of the mechanisms involved and of the mode of action of the drugs themselves. There is still much to be learned, especially about the wider effects of the drugs, their precise mode and site of action and about differences between the different preparations. ACE inhibitors are of proven benefit to patients with chronic congestive heart failure and are the latest in the series of drugs used in the treatment of hypertension. Interest in the treatment of hypertension has paralleled the development of hypotensive drugs and the realisation that long-term prognosis could be significantly improved. The treatment of hypertension has progressed in stages following the development of a succession of increasingly effective drugs, each allowing a greater proportion of patients to be treated with fewer and fewer side-effects. First, the ganglion-blocking agents such as hexamethonium and guan ethidine transformed the outlook for patients with malignant hypertension but proved too unpleasant for routine use in other forms of hypertension Cardiology General Practice / Family Medicine Pharmacology/Toxicology Family medicine Toxicology Strube, George aut Erscheint auch als Druck-Ausgabe 9780792389637 Erscheint auch als Druck-Ausgabe 9789401057370 Erscheint auch als Druck-Ausgabe 9789401139014 https://doi.org/10.1007/978-94-011-3900-7 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Strube, Gillian Strube, George ACE Inhibitors in Hypertension A Guide for General Practitioners Cardiology General Practice / Family Medicine Pharmacology/Toxicology Family medicine Toxicology |
| title | ACE Inhibitors in Hypertension A Guide for General Practitioners |
| title_auth | ACE Inhibitors in Hypertension A Guide for General Practitioners |
| title_exact_search | ACE Inhibitors in Hypertension A Guide for General Practitioners |
| title_full | ACE Inhibitors in Hypertension A Guide for General Practitioners by Gillian Strube, George Strube |
| title_fullStr | ACE Inhibitors in Hypertension A Guide for General Practitioners by Gillian Strube, George Strube |
| title_full_unstemmed | ACE Inhibitors in Hypertension A Guide for General Practitioners by Gillian Strube, George Strube |
| title_short | ACE Inhibitors in Hypertension |
| title_sort | ace inhibitors in hypertension a guide for general practitioners |
| title_sub | A Guide for General Practitioners |
| topic | Cardiology General Practice / Family Medicine Pharmacology/Toxicology Family medicine Toxicology |
| topic_facet | Cardiology General Practice / Family Medicine Pharmacology/Toxicology Family medicine Toxicology |
| url | https://doi.org/10.1007/978-94-011-3900-7 |
| work_keys_str_mv | AT strubegillian aceinhibitorsinhypertensionaguideforgeneralpractitioners AT strubegeorge aceinhibitorsinhypertensionaguideforgeneralpractitioners |